Literature DB >> 16236241

Assaying Bcr-Abl kinase activity and inhibition in whole cell extracts by phosphorylation of substrates immobilized on agarose beads.

Ding Wu1, Evan Nair-Gill, Dorie A Sher, Laurie L Parker, Jennifer M Campbell, Mariah Siddiqui, Wendy Stock, Stephen J Kron.   

Abstract

There is a current and increasing demand for simple, robust, nonradioactive assays of protein tyrosine kinase activity with applications for clinical diagnosis and high-throughput screening of potential molecularly targeted therapeutic agents. One significant challenge is to detect and measure the activity of specific kinases with key roles in cell signaling as an approach to distinguish normal cells from cancer cells and as a means of evaluating targeted drug efficacy and resistance in cancer cells. Here, we describe a method in which kinase substrates fused to glutathione-S-transferase and immobilized on glutathione agarose beads are phosphorylated, eluted, and then assayed to detect kinase activity. The activity of recombinant, purified c-Abl kinase or Bcr-Abl kinase in whole cell extracts can be detected with equivalent specificity, sensitivity, and reproducibility. Similarly, inhibition of recombinant c-Abl or Bcr-Abl in cells or cell extracts by imatinib mesylate and other Bcr-Abl targeted kinase inhibitors is readily assayed. This simple kinase assay is sufficiently straightforward and robust for use in clinical laboratories and is potentially adaptable to high-throughput assay formats.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16236241      PMCID: PMC4562293          DOI: 10.1016/j.ab.2005.09.001

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  43 in total

1.  Comparison of effects of the tyrosine kinase inhibitors AG957, AG490, and STI571 on BCR-ABL--expressing cells, demonstrating synergy between AG490 and STI571.

Authors:  X Sun; J E Layton; A Elefanty; G J Lieschke
Journal:  Blood       Date:  2001-04-01       Impact factor: 22.113

Review 2.  The molecular biology of chronic myeloid leukemia.

Authors:  M W Deininger; J M Goldman; J V Melo
Journal:  Blood       Date:  2000-11-15       Impact factor: 22.113

3.  Phosphopeptide analysis by positive and negative ion matrix-assisted laser desorption/ionization mass spectrometry.

Authors:  K Janek; H Wenschuh; M Bienert; E Krause
Journal:  Rapid Commun Mass Spectrom       Date:  2001       Impact factor: 2.419

Review 4.  Applications of one-bead one-compound combinatorial libraries and chemical microarrays in signal transduction research.

Authors:  Kit S Lam; Ruiwu Liu; Suzanne Miyamoto; Alan L Lehman; Joseph M Tuscano
Journal:  Acc Chem Res       Date:  2003-06       Impact factor: 22.384

5.  A multiplexed homogeneous fluorescence-based assay for protein kinase activity in cell lysates.

Authors:  Melissa D Shults; Kevin A Janes; Douglas A Lauffenburger; Barbara Imperiali
Journal:  Nat Methods       Date:  2005-03-23       Impact factor: 28.547

Review 6.  Protein tyrosine kinases: structure, substrate specificity, and drug discovery.

Authors:  F A al-Obeidi; J J Wu; K S Lam
Journal:  Biopolymers       Date:  1998       Impact factor: 2.505

Review 7.  Tyrosine kinase inhibitors and the dawn of molecular cancer therapeutics.

Authors:  Raoul Tibes; Jonathan Trent; Razelle Kurzrock
Journal:  Annu Rev Pharmacol Toxicol       Date:  2005       Impact factor: 13.820

8.  Direct binding of CRKL to BCR-ABL is not required for BCR-ABL transformation.

Authors:  C Heaney; K Kolibaba; A Bhat; T Oda; S Ohno; S Fanning; B J Druker
Journal:  Blood       Date:  1997-01-01       Impact factor: 22.113

Review 9.  Basic science going clinical: molecularly targeted therapy of chronic myelogenous leukemia.

Authors:  Michael W N Deininger
Journal:  J Cancer Res Clin Oncol       Date:  2003-11-07       Impact factor: 4.553

10.  Structural basis for the autoinhibition of c-Abl tyrosine kinase.

Authors:  Bhushan Nagar; Oliver Hantschel; Matthew A Young; Klaus Scheffzek; Darren Veach; William Bornmann; Bayard Clarkson; Giulio Superti-Furga; John Kuriyan
Journal:  Cell       Date:  2003-03-21       Impact factor: 41.582

View more
  7 in total

1.  Photocleavable peptide-oligonucleotide conjugates for protein kinase assays by MALDI-TOF MS.

Authors:  Guangchang Zhou; Faraz Khan; Qing Dai; Juliesta E Sylvester; Stephen J Kron
Journal:  Mol Biosyst       Date:  2012-07-06

2.  Phosphoprotein profiling by PA-GeLC-MS/MS.

Authors:  Kolbrun Kristjansdottir; Donald Wolfgeher; Nick Lucius; David Sigfredo Angulo; Stephen J Kron
Journal:  J Proteome Res       Date:  2008-05-30       Impact factor: 4.466

Review 3.  Peptide reporters of kinase activity in whole cell lysates.

Authors:  Ding Wu; Juliesta E Sylvester; Laurie L Parker; Guangchang Zhou; Stephen J Kron
Journal:  Biopolymers       Date:  2010       Impact factor: 2.505

4.  A bead-based activity screen for small-molecule inhibitors of signal transduction in chronic myelogenous leukemia cells.

Authors:  Juliesta E Sylvester; Stephen J Kron
Journal:  Mol Cancer Ther       Date:  2010-04-27       Impact factor: 6.261

5.  A magnetic bead-based protein kinase assay with dual detection techniques.

Authors:  Guangchang Zhou; Juliesta E Sylvester; Ding Wu; Darren R Veach; Stephen J Kron
Journal:  Anal Biochem       Date:  2010-08-31       Impact factor: 3.365

6.  A peptide biosensor for detecting intracellular Abl kinase activity using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  Ekaterina A Placzek; Michael P Plebanek; Andrew M Lipchik; Stephanie R Kidd; Laurie L Parker
Journal:  Anal Biochem       Date:  2009-10-07       Impact factor: 3.365

7.  A multiple reaction monitoring (MRM) method to detect Bcr-Abl kinase activity in CML using a peptide biosensor.

Authors:  Tzu-Yi Yang; Christie L Eissler; Mark C Hall; Laurie L Parker
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.